
GRDN does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for GRDN and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for GRDN and 80,000+ other tickers.
See exactly how GRDN's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for GRDN and 80,000+ other tickers.
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and…

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that it will release second quarter 2026 financial results after market close on Thursday, August 6, 2026. Management will host a conference call to discuss the results at 4:30 p.m. Eastern Time. Conference Call Details The conference call will be available via audio webcast at https://investors.guardianpharmacy.com and can also be accessed by dialing +1 (833) 461-5787 for participants located in the United.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) has acquired Wellness Concepts, a long-term care pharmacy based in Grottoes, Virginia.

Do you have more faith in DuPont analysis than in simple ROE calculation? Tap CASY, ECG, GRDN, EXPD and MAMA for gains.

Guardian Pharmacy (GRDN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ATLANTA--(BUSINESS WIRE)--Guardian Pharmacy Services, Inc. (NYSE: GRDN) today announced that Kendall Forbes, who has served as Executive Vice President of Sales & Operations since 2004, has decided to retire, effective as of July 1, 2026. Upon Mr. Forbes's retirement, David Morris, currently Executive Vice President and Chief Financial Officer of Guardian will assume the role of Chief Operating Officer. In connection with Mr. Morris' new role, Will Mudd, Senior Vice President, Finance, has b.